Aytu Biopharma (AYTU) Selling, General & Administrative (2010 - 2026)
Aytu Biopharma's Selling, General & Administrative was $4.31 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 16.5% from $3.7 million a year earlier but down 13.4% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Selling, General & Administrative at Aytu Biopharma came in at $19.27 million, up 10.9% from FY2025.
- Selling, General & Administrative shows a five-year compound annual growth rate of -5.4% (FY2021 to FY2026).
- In earlier fiscal years, Selling, General & Administrative was $17.38 million in FY2025 (-12.9%), $19.95 million in FY2024 (-30.3%), $28.63 million in FY2023 (-8.1%) and $31.17 million in FY2022 (+22.2%).
- Quarterly Selling, General & Administrative has moved between $3.7 million (fiscal Q4 2025) and $8.22 million (fiscal Q1 2022) over five years.
- Compared with a year earlier, Selling, General & Administrative has increased for three straight quarters, with an average decline of 0.2% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was fiscal Q1 2022 (growth of 51.6%); the worst was fiscal Q2 2024 (a decline of 40.1%).
- Per Business Quant data, AYTU's Selling, General & Administrative in the three fiscal quarters before Q4 2026 was $4.97 million (Q3 2026), $5.07 million (Q2 2026) and $4.92 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Aytu Biopharma | 22.17 Mn | -93.50 Mn | 10.41 Mn | 4.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.31 Mn |
| Mar 31, 2026 | 4.97 Mn |
| Dec 31, 2025 | 5.07 Mn |
| Sep 30, 2025 | 4.92 Mn |
| Jun 30, 2025 | 3.70 Mn |
| Mar 31, 2025 | 4.11 Mn |
| Dec 31, 2024 | 4.45 Mn |
| Sep 30, 2024 | 5.13 Mn |
| Jun 30, 2024 | 4.03 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Dec 31, 2023 | 4.80 Mn |
| Sep 30, 2023 | 6.30 Mn |
| Jun 30, 2023 | 6.11 Mn |
| Mar 31, 2023 | 7.18 Mn |
| Dec 31, 2022 | 8.02 Mn |
| Sep 30, 2022 | 7.32 Mn |
| Jun 30, 2022 | 7.38 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 7.95 Mn |
| Sep 30, 2021 | 8.22 Mn |
API Access
Aytu Biopharma Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();